ACADIA Pharmaceuticals (ACAD) Income Statement: Revenue & Earnings

ACADIA Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

ACADIA Pharmaceuticals Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	957.80	726.44	517.24	484.15	441.76	339.08	223.81
Cost of Revenue	81.84	41.64	10.17	19.14	286.88	11.34	18.33
Gross Profit	875.96	684.80	507.07	465.00	154.88	327.73	205.48
Operating Expenses
Research & Development	303.25	351.62	361.58	239.42	319.13	240.39	187.16
Selling, General & Administrative	488.43	406.56	369.09	396.03	388.66	325.64	265.76
Operating Expenses	645.16	758.18	730.67	635.44	388.66	566.02	452.92
Operating Income	230.79	-73.38	-223.60	-170.44	-233.79	-246.55	-247.44
Other Income/Expense
Interest Income	25.46	17.23	6.61	0.59	6.61	0.00	5.35
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	27.28	-5.11	3.54	-2.33	1.00	-1.00	-1.84
Income
Income Before Tax	258.08	-51.04	-213.44	-167.52	-280.97	-234.38	-243.94
Income Tax Expense	31.62	10.25	2.53	0.35	0.61	0.88	1.26
Net Income	226.45	-61.29	-215.98	-167.87	-281.58	-235.26	-245.19
Net Income - Continuous Operations	226.45	-61.29	-215.98	-167.87	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	100.16	-45.44	-221.57	-167.10	-230.85	-235.20	-244.44
EBIT	258.08	-51.04	-223.60	-170.44	-233.79	-234.38	-247.44
Depreciation & Amortization	15.88	1.50	2.00	2.20	2.93	1.30	0.00
Earnings Per Share
Basic EPS	1.00	-	-1.00	-1.00	-2.00	-2.00	-2.00
Diluted EPS	1.00	-	-1.00	-1.00	-2.00	-2.00	-2.00
Basic Shares Outstanding	165.72	0.16	0.16	160.49	157.33	147.20	126.58
Diluted Shares Outstanding	166.36	0.16	0.16	160.49	157.33	147.20	126.58